NASDAQ: NERV       Minerva Neuroscie
Last Price Today's Change   Day's Range   Trading Volume
2.80   -0.16 (5.41%)  2.79 - 2.99  388,365


Avg Volume (4 weeks):625,938
4 Weeks Range:2.79 - 3.54
4 Weeks Price Volatility (%):
52 Weeks Range:2.15 - 4.115
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. The company primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. This portfolio includes four compounds, schizophrenia, insomnia, major depressive disorder and Parkinson's disease. Its product portfolio and potential indications include MIN-101 for the treatment of schizophrenia; MIN-202, for the treatment of insomnia disorder and major depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2805  4156  462  3488 

Top 10 Active Counters
 AMC 59.04+2.04 
 TRCH 5.07+1.49 
 ALF 6.97+3.56 
 WISH 11.270.00 
 OCGN 6.26+0.13 
 SNDL 1.00-0.06 
 CLSD 4.16+1.14 
 DKNG 48.51-2.11 
 AAPL 129.64-0.84 
 F 15.00+0.13